Loading...
Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?
Mucormycosis is a life-threatening infection which causes unacceptably high morbidity and mortality despite treatment. Therefore, a vaccine to prevent mucormycosis is desirable. A major barrier to developing an anti-mucormycosis vaccine is the perception that such a vaccine would not be cost-effecti...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2793326/ https://ncbi.nlm.nih.gov/pubmed/18798118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13693780802326001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|